CINCINNATI--(BUSINESS WIRE)--Devicor® Medical Products, Inc. (Devicor), a portfolio company of GTCR, a leading private equity firm, announced today the acquisition of the HydroMARK® breast biopsy marker portfolio and related assets from Biopsy Sciences, LLC. "We are proud to add HydroMARK to our existing family of Mammotome® markers," said Devicor CEO Tom Daulton. "Combining HydroMARK with our existing MammoMARK®, MammoStar® and MicroMARK® products allows us to offer customers a complete portfolio of tissue markers that meets all of their breast biopsy marking needs.”
Help employers find you! Check out all the jobs and post your resume.
